Company news

Envoy Medical, Inc. news in 2026

Envoy Medical, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Envoy Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

November 10, 2026

Envoy and LACI Collaborate to Bring Electric Car Sharing Across New Jersey Through $8.5 Million NJDEP-Funded Initiative

November 9, 2026

Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress

November 5, 2026

Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8: 00 A.M. ET on Thursday, November 5th

October 28, 2026

Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th

October 27, 2026

Envoy Medical Announces Reverse Stock Split

October 22, 2026

Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design

October 20, 2026

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

October 12, 2026

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

September 22, 2026

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

September 2, 2026

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

August 10, 2026

Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial

July 21, 2026

Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant

July 14, 2026

Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device

June 30, 2026

Envoy Medical Terminates At-the-Market (ATM) Equity Facility

June 25, 2026

Envoy Medical to Present at Investor Conferences on June 25th

June 18, 2026

Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th

June 3, 2026

Envoy Medical (NASDAQ: COCH) Signs Multi-Part Series With New to The Street

June 1, 2026

Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology

May 20, 2026

Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant

May 11, 2026

Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

April 28, 2026

Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

April 21, 2026

Envoy Medical Appoints Chas McKhann to Board of Directors

April 15, 2026

Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant

March 31, 2026

Envoy Medical Reports Full Year 2025 Financial Results

March 23, 2026

Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

March 10, 2026

Envoy Medical Regains Compliance with Nasdaq Listing Requirement

February 24, 2026

Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

February 22, 2026

Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

February 19, 2026

Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

February 17, 2026

Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering

February 12, 2026

Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering

February 11, 2026

Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5

January 29, 2026

Calls in 2026

Decks in 2026